Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles
Anhui Hyea Aromas (300886.SZ) plans a private placement to raise no more than RMB118 million.
JXR (01951) repurchased 1.598 million shares on November 10 for approximately HK$3.6875 million.
Shenwan Hongyuan Group Hong Kong (00218): Liang Jun resigns from the position of Executive Director of the Board.
Anhui Hyea Aromas (300886.SZ) plans a private placement to raise no more than RMB118 million.
JXR (01951) repurchased 1.598 million shares on November 10 for approximately HK$3.6875 million.
Shenwan Hongyuan Group Hong Kong (00218): Liang Jun resigns from the position of Executive Director of the Board.
